1471-0528/asset/BJO_left.gif?v=1&s=0fb87361cdb6be25fdf05019eed6d47f5143f610)
1471-0528/asset/olbannerright.gif?v=1&s=3892ef16ff18d6834c302faf85268a49f5fc588f)
DOUBLE BLIND TRIAL OF RITODRINE AND PLACEBO IN TWIN PREGNANCY
Article first published online: 23 AUG 2005
DOI: 10.1111/j.1471-0528.1979.tb11270.x
Issue
1471-0528/asset/cover.gif?v=1&s=b4e1d96c46e18c61210d584b63c13ee375cf562b "BJOG: An International Journal of Obstetrics & Gynaecology")
BJOG: An International Journal of Obstetrics & Gynaecology
Volume 86, Issue 9, pages 706–709, September 1979
Additional Information
How to Cite
O'Connor, M. C., Murphy, H. and Dalrymple, I. J. (1979), DOUBLE BLIND TRIAL OF RITODRINE AND PLACEBO IN TWIN PREGNANCY. BJOG: An International Journal of Obstetrics & Gynaecology, 86: 706–709. doi: 10.1111/j.1471-0528.1979.tb11270.x
Publication History
- Issue published online: 23 AUG 2005
- Article first published online: 23 AUG 2005
- Abstract
- References
- Cited By
Summary
In a double blind trial, 25 patients with twin pregnancy were given 40 mg of ritodrine hydrochloride by mouth daily and 24 similar patients received a placebo. The ritodrine group had no significant prolongation of pregnancy nor increase in birth weight, and a high incidence of side effects occurred.